Search

everythinglearnresearchcommunity

for

Search:↓

The compound 4c effectively inhibits the enzyme linked to hair loss.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

New compounds show promise as nonsteroidal treatments for hair loss.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

The compounds tested could potentially treat hair loss and alopecia.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New progesterone-based compounds can block male hormones.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Researchers created a new method to measure brain steroids, finding higher levels of certain steroids and changes due to a drug.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

A simple and eco-friendly method was developed to make finasteride Form-I using water.

Certain drugs that block specific enzymes can help treat prostate diseases.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

New methods for measuring dutasteride are effective and reliable.

A new, safer method to make finasteride from progesterone is effective for industrial use.